ArticleBritish journal of cancer2017

Nintedanib selectively inhibits the activation and tumour-promoting effects of fibroblasts from lung adenocarcinoma patients.

M Gabasa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.